ARWR logo

ARWR

Arrowhead Pharmaceuticals Inc.

$22.03
-$0.31(-1.39%)
24
Overall
--
Value
18
Tech
31
Quality
Market Cap
$2.93B
Volume
2.39M
52W Range
$9.57 - $27.34
Target Price
$43.71
Order:

Income Statement

MetricTrendChart
2015
Sep
2016
Sep
2017
Sep
2018
Sep
2019
Sep
2020
Sep
2021
Sep
2022
Sep
2023
Sep
2024
Sep
REVENUE
Total Revenue
$382.0K$158.3K$31.4M$16.1M$168.8M$88.0M$138.3M$243.2M$240.7M$3.6M
Total Revenue
$382.0K$158.3K$31.4M$16.1M$168.8M$88.0M$138.3M$243.2M$240.7M$3.6M
GROSS PROFIT
Gross Profit
$382.0K$158.3K$31.4M$16.1M$168.8M$88.0M$138.3M$243.2M$240.7M$3.6M
OPERATING EXPENSES
Operating Expenses
$94.5M$74.1M$-68.4M$-72.1M$107.6M$181.2M$287.3M$421.7M$445.7M$604.6M
Research & Development
$67.6M$41.5M$50.9M$53.0M$81.0M$128.9M$206.3M$297.3M$353.2M$505.9M
Research Expense
$47.3M$41.5M$50.9M$53.0M$81.0M$128.9M$206.3M$297.3M$353.2M$505.9M
Selling, General & Administrative
$7.9M$9.9M$17.5M$19.1M$26.6M$52.3M$81.0M$124.4M$92.5M$98.8M
General & Administrative Expenses
$7.9M$9.9M$17.5M$19.1M$26.6M$52.3M$81.0M$124.4M$92.5M$98.8M
Salaries & Wages
$16.6M$19.5M$25.2M----------$78.1M$67.1M
Depreciation & Amortization
$2.3M$3.3M$-3.0M$-3.0M$2.7M$4.2M$6.6M$8.7M$10.7M$16.9M
Depreciation & Amortization
$2.3M$3.3M$4.7M$-3.0M$2.7M$4.2M$6.6M$8.7M$10.7M$16.9M
Amortization
$-1.0M$-1.7M$-1.7M$-1.7M$1.7M$1.7M$1.7M$1.7M$1.7M$1.7M
Other Operating Expenses
$10.1M------------$9.8M$-3.0M$-3.4M
OPERATING INCOME
Operating income
$-94.1M$-74.0M$-37.0M$-55.9M$61.2M$-93.2M$-149.0M$-178.5M$-205.0M$-601.1M
EBITDA
$-88.5M$-66.9M$-29.7M$-49.7M$72.6M$-87.2M$-132.6M$-162.3M$-194.0M$-593.9M
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
----------------$18.3M--
Intinc
$729.2K$265.8K$415.1K$1.0M$7.0M$9.2M$6.1M$5.0M----
Net Non-Operating Interest Income/Expense
$729.2K$265.8K$415.1K$1.0M$7.0M$9.2M$6.1M$-5.0M$3.0M--
Gain on Sale of Securities
$2.9M$-301.0K$890.4K$432.1K------------
Other Income/Expense
$-1.4M$-5.6M$-2.2M$-439.6K$-22.4M$583.0K$-2.1M$765.0K$-16.8M$-21.0M
Other Special Charges
$417.9K$57.4K$1.3M$7.5K$22.4M$-583.0K$2.1M$5.8M$16.8M$21.0M
SPECIAL ITEMS
Restructring And Mn A Income
--------$-90.3M$-279.0M--------
Special Income Charges
--$-2.1M----$90.3M$279.0M--------
Impairment of Capital Assets
--$2.1M----------------
PRE-TAX INCOME
EBIT
$-91.9M$-70.1M$-34.4M$-54.4M$68.1M$-93.2M$-140.8M$-172.7M$-206.5M$-612.5M
Pre-Tax Income
$-91.9M$-70.1M$-34.4M$-54.4M$68.1M$-84.6M$-140.8M$-172.7M$-206.5M$-612.5M
INCOME TAX
Tax Provision
$2.4K$2.4K$2.4K$2.4K$173.6K$2.0K$2.0K$3.8M$2.8M$-2.8M
NET INCOME
Net Income
$-91.9M$-81.7M$-34.4M$-54.5M$68.0M$-84.6M$-140.8M$-176.1M$-205.3M$-599.5M
Net Income (Continuing Operations)
$-91.9M$-81.7M$-34.4M$-54.5M$68.0M$-84.6M$-140.8M$-176.5M$-209.3M$-609.7M
Net Income (Discontinued Operations)
$-91.9M$-81.7M$-34.4M$-54.5M$68.0M$-84.6M$-140.8M$-176.1M$-205.3M$-599.5M
Net Income (Common Stockholders)
$-91.9M$-81.7M$-34.4M$-54.5M$68.0M$-84.6M$-140.8M$-176.1M$-205.3M$-599.5M
Normalized Income
------------------$-615.2M
TOTALS
Total Expenses
$94.5M$74.1M$-68.4M$-72.1M$107.6M$181.2M$287.3M$421.7M$445.7M$604.6M
SHARE & EPS DATA
Average Shares Outstanding
$57.4M$61.1M$73.9M$83.6M$93.9M$100.7M$103.7M$105.4M$106.8M$119.8M
Average Shares Outstanding (Diluted)
$57.4M$61.1M$73.1M$83.6M$98.6M$100.7M$103.7M$105.4M$106.8M$119.8M
Shares Outstanding
$59.6M$74.2M$74.8M$92.2M$95.7M$102.8M$104.5M$106.0M$107.4M$124.4M
Basic EPS
$-1.6$-1.34--$-0.65$0.72$-0.84$-1.36$-1.67$-1.92$-5
Basic EPS (Continuing Operations)
$-1.6$-1.34----$0.72$-0.84$-1.36$-1.67$-1.92$-5
Diluted EPS
$-1.6$-1.34$-0.47$-0.65$0.69$-0.84$-1.36$-1.67$-1.92$-5
Diluted EPS (Continuing Operations)
--------$0.69$-0.84$-1.36$-1.67$-1.92$-5
OTHER METRICS
Development Expense
$20.4M------------------
Excise Taxes
--$11.6M----------------
Gain On Sale Of P P E
$19.2K------------------
Minority Interests
--------$244.0M$461.8M$408.8M$431.0K$4.0M$10.2M
Other Gand A
$7.9M$9.9M$17.5M$19.1M$26.6M$52.3M$81.0M$124.4M$92.5M$98.8M
Other Impairment Of Capital Assets
--$-944.9K----------------
Rent And Landing Fees
----$17.5M$19.1M$1.7M----------
Restruct
--------$-90.3M$-279.0M--------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2ARWR$22.03-1.4%2.39M
3
4
5
6

Get Arrowhead Pharmaceuticals Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.